Evaluating the Efficacy of Immunotherapy in Fragile Hospitalized Patients
The effectiveness of immunotherapy in fragile hospitalized patients is compromised, although they exhibit significant irAE. Excellent performance status, fitness to receive many IO treatments, and normal levels of serum LDH and albumin may be useful in selecting patients who will benefit from immunotherapy.
Authors
- Charles Vincent Rajadurai (ORCID: https://orcid.org/0000-0001-8067-3376)
- Catherine Allard (ORCID: https://orcid.org/0000-0002-8829-4984)
- Mandy Malick (ORCID: https://orcid.org/0009-0003-3571-7060)
- Michel Pavic (ORCID: https://orcid.org/0000-0002-7057-7492)
- Gabriel Gagnon
Institutions
- Université de Sherbrooke (CA)
- McGill University Health Centre (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
Publication Details
- Journal
- Current Oncology
- Published
- 2024-11-10
- DOI
- https://doi.org/10.3390/curroncol31110518
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00